Biblio

Author Title [ Type

] Year

Filters: First Letter Of Title is S [Clear All Filters]

Journal Article

Zhang S, Wang Z, Jiang J, Feng G, Fan S. 's multifaceted role in mitigating ionizing radiation-induced injury in . Food Funct. 2024.

Chen H, Zhang B, Weir MD, Homayounfar N, Fay GGarcia, Martinho F, Lei L, Bai Y, Hu T, Xu HHK. S. mutans gene-modification and antibacterial resin composite as dual strategy to suppress biofilm acid production and inhibit caries. J Dent. 2020:103278.

Anon. (S039) ALDH-Expressing Cancer Stem Cells Are Associated With Inferior Survival in Patients With Resected Pancreatic Adenocarcinoma Treated With Adjuvant Chemoradiation. Oncology (Williston Park). 2014;28(1S).

Borgmann-Staudt A, Jantke A, Hinz S, Beckmann M, Dittrich R, Lotz L, Balcerek M. S1 Guideline: Impairment of gonadal function After Cancer in Childhood and Adolescence. Klin Padiatr. 2023.

Tu Y, Xie P, Du X, Fan L, Bao Z, Sun G, Zhao P, Chao H, Li C, Zeng A, et al. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop. J Cell Mol Med. 2019.

Liu CC, Du H, Wang Y, Gong N, Qi W, Zhou X, Shi L. S100A11 regulates nasal epithelial cell remodeling and inflammation in CRSwNPs via the RAGE-mediated AMPK-STAT3 pathway. Mol Immunol. 2021;140:35-46.

Deng S, Zhang Y, Liao Z, Huang J, Huang R, Li Z. S100A4 plays a key role in TRPV3 ion channel expression and its electrophysiological function. Neurosci Lett. 2021:135999.

Hiruta A, Oguri Y, Yokoi A, Matsumoto T, Oda Y, Tomohiro M, Hashimura M, Jiang Z, Tochimoto M, Nakagawa M, et al. S100A4/non-muscle myosin IIA/p53 axis contributes to aggressive features in ovarian high-grade serous carcinoma. Am J Pathol. 2020.

Wang Y, Kang X, Kang X, Yang F. S100A6: molecular function and biomarker role. Biomark Res. 2023;11(1):78.

Cheng P, Eksioglu EA, Chen X, Kandell W, Le Trinh T, Cen L, Qi J, Sallman DA, Zhang Y, Tu N, et al. S100A9-induced overexpression of PD-1/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromes. Leukemia. 2019.

Yang T, Cheng J, You J, Yan B, Liu H, Li F. S100B promotes chemoresistance in ovarian cancer stem cells by regulating p53. Oncol Rep. 2018.

Olson LC, Nguyen T, Sabalewski EL, Puetzer JL, Schwartz Z, McClure MJ. S100b Treatment Overcomes RAGE Signaling Deficits in Myoblasts on Advanced Glycation End-product Cross-linked Collagen and Promotes Myogenic Differentiation. Am J Physiol Cell Physiol. 2024.

Okus FZehra, Azizoglu ZBusra, Canatan H, Eken A. S1P analogues SEW2871, BAF312 and FTY720 affect human Th17 and Treg generation ex vivo. Int Immunopharmacol. 2022;107:108665.

Romani R, Manni G, Donati C, Pirisinu I, Bernacchioni C, Gargaro M, Pirro M, Calvitti M, Manni G, Bagaglia F, et al. S1P promotes migration, differentiation and immune regulatory activity in amniotic-fluid-derived stem cells. Eur J Pharmacol. 2018.

Sindi M, Hecker C, Issberner A, Ruck T, Meuth SG, Albrecht P, Dietrich M. S1PR-1/5 modulator RP-101074 shows beneficial effects in a model of central nervous system degeneration. Front Immunol. 2023;14:1234984.

Dillmann C, Mora J, Olesch C, Brüne B, Weigert A. S1PR4 is required for plasmacytoid dendritic cell differentiation. Biol Chem. 2015.

Wang F, Zhao S, Gu Z, Zhao X, Yang N, Guan L, Liu T, Wang L, Fang S, Zhu C, et al. S1PR5 regulates NK cell responses in preventing graft-versus-host disease while preserving graft-versus-tumour activity in a murine allogeneic haematopoietic stem cell transplantation model. Hematol Oncol. 2019.

Kreuter A, Moinzadeh P, Kinberger M, Horneff G, Worm M, Werner RN, Hammacher A, Krieg T, Wenzel J, Oeschger M, et al. S2k guideline: Diagnosis and therapy of localized scleroderma. J Dtsch Dermatol Ges. 2024.

Lee JEun, Lim MSun, Park JHyun, Park CHwan, Koh HChul. S6K Promotes Dopaminergic Neuronal Differentiation Through PI3K/Akt/mTOR-Dependent Signaling Pathways in Human Neural Stem Cells. Mol Neurobiol. 2015.

Ghosh J, Kobayashi M, Ramdas B, Chatterjee A, Ma P, Mali RSingh, Carlesso N, Liu Y, Plas DR, Chan RJ, et al. S6K1 regulates hematopoietic stem cell self-renewal and leukemia maintenance. J Clin Invest. 2016.

Juan AH, Sartorelli V. S6K1ing to ResTOR Adipogenesis with Polycomb. Mol Cell. 2016;62(3):325-326.

Matelska D, Purta E, Panek S, Boniecki MJ, Bujnicki JM, Dunin-Horkawicz S. S6:S18 ribosomal protein complex interacts with a structural motif present in its own mRNA. RNA. 2013.

Li J-Y, Xiao T, Yi H-M, Yi H, Feng J, Zhu J-F, Huang W, Lu S-S, Zhou Y-H, Li X-H, et al. S897 phosphorylation of EphA2 is indispensable for EphA2-dependent nasopharyngeal carcinoma cell invasion, metastasis and stem properties. Cancer Lett. 2018.

Wang X, Wen S, Du X, Zhang Y, Yang X, Zou R, Feng B, Fu X, Jiang F, Zhou G, et al. SAA suppresses α-PD-1 induced anti-tumor immunity by driving T2 polarization in lung adenocarcinoma. Cell Death Dis. 2023;14(11):718.

Rybinska I, Mangano N, Romero-Cordoba SL, Regondi V, Ciravolo V, De Cecco L, Maffioli E, Paolini B, Bianchi F, Sfondrini L, et al. SAA1-dependent reprogramming of adipocytes by tumor cells is associated with triple negative breast cancer aggressiveness. Int J Cancer. 2024.

Pages